CN103690806A - External application medicament for treating facial paralysis and preparation and use methods thereof - Google Patents

External application medicament for treating facial paralysis and preparation and use methods thereof Download PDF

Info

Publication number
CN103690806A
CN103690806A CN201310683315.6A CN201310683315A CN103690806A CN 103690806 A CN103690806 A CN 103690806A CN 201310683315 A CN201310683315 A CN 201310683315A CN 103690806 A CN103690806 A CN 103690806A
Authority
CN
China
Prior art keywords
parts
facial paralysis
radix
topical agent
crude drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201310683315.6A
Other languages
Chinese (zh)
Other versions
CN103690806B (en
Inventor
卞佳林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bian Jialin
Original Assignee
Qingdao Bairuiji Biological Engineering Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qingdao Bairuiji Biological Engineering Co Ltd filed Critical Qingdao Bairuiji Biological Engineering Co Ltd
Priority to CN201310683315.6A priority Critical patent/CN103690806B/en
Publication of CN103690806A publication Critical patent/CN103690806A/en
Application granted granted Critical
Publication of CN103690806B publication Critical patent/CN103690806B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses an external application medicament for treating facial paralysis. The external application medicament comprises the following bulk drugs in parts by weight: 6-8 parts of cogongrass rhizome, 8-12 parts of poria cocos, 10-15 parts of platycodon root, 10-12 parts of white sandalwood, 10-20 parts of honeysuckle flower, 6-9 parts of cicada shell, 12-20 parts of tall gastrodia tuber, 10-13 parts of liquoric root, 6-9 parts of red-rooted salvia root and 10-15 parts of sugar candy. Compared with the prior art, the external application medicament has the advantages of remarkable medicinal effect, low price, no toxic or side effect, avoidance of drug tolerance of a patient and prevention of relapse, and is suitable for clinical application; preparation and use methods of the medicament are simple, convenient and feasible, and are independent of the technical contingency of medical personnel.

Description

A kind of topical agent of facial paralysis and preparation and application thereof
Technical field
The present invention relates to Chinese medicine preparation and preparation method thereof, relate in particular to a kind of topical agent and preparation and application thereof of facial paralysis.
Background technology
Facial paralysis, also claims facial neuritis, facial paralysis, bell's palsy, hunter syndrome, is commonly called as " wapperijaw wind ", " facial paralysis ", " hanging skew wind " etc., is to take a kind of commonly encountered diseases that facial expression muscle group dyskinesia is principal character.The cause of disease of facial paralysis is still not very clear, thinks due to due to nervus facialis microcirculation disturbance more.Overtired, chilling after antiperspirant, viral infection, mental pressure, inherited genetic factors etc. can make people suffer from facial paralysis.Because the cause of disease is complicated, and indefinite, the method for the treatment of is also unified not to the utmost.Common Therapeutic Method has Drug therapy, naturopathy, treatment by Chinese herbs and acupuncture and moxibustion therapy etc.The multiplex hormone of Drug therapy, B vitamin, microcirculation improving agent bendazol, low molecular dextran etc.Conventional naturopathy has ultrashort wave, low mid-frequency current therapy, laser, medicine importing etc.Treatment by Chinese herbs has many ancient prescriptions, proved recipe, and as QIANZHENGSAN, eight tastes, to exempt from wind soup, Bel loose etc.In clinical practice, find, although above-mentioned Therapeutic Method has the case of producing effects, its scope of application is all fuzzyyer, and patient's selection is often more difficult, and many patients have expended mint of money in examination repeatedly in controlling, and have missed golden hour.Acupuncture and moxibustion therapy is one of Main Means of Chinese traditional treatment facial paralysis, but still disputable for the selection of Acupuncture opportunity plays, and it selects cave and maneuver also different, standardization level is low, occasionality and uncertainty are rather outstanding, harsher to doctor individual's requirement, are difficult to universal enforcement.
Summary of the invention
Goal of the invention: in order to solve the existing problem of prior art, the invention provides a kind of drug effect is remarkable, with low cost, be difficult for the facial paralysis of recurrence topical agent and preparation and application thereof.
Technical scheme: for achieving the above object, the present invention is by the following technical solutions: a kind of topical agent of facial paralysis, comprises the crude drug of following parts by weight: 6~8 parts of Rhizoma Imperataes, 8~12 parts, Poria, 10~15 parts of RADIX PLATYCODIs, 10~12 parts of Santalum albums, 10~20 parts of Flos Loniceraes, 6~9 parts of Periostracum Cicadaes, 12~20 parts, Rhizoma Gastrodiae, 10~13 parts, Radix Glycyrrhizae, 6~9 parts of Radix Salviae Miltiorrhizaes, 10~15 parts, crystal sugar.
As a further improvement on the present invention, described each crude drug consumption is composed as follows according to quality meter: the crude drug that comprises following parts by weight: 7 parts of Rhizoma Imperataes, 10 parts, Poria, 13 parts of RADIX PLATYCODIs, 11 parts of Santalum albums, 15 parts of Flos Loniceraes, 7 parts of Periostracum Cicadaes, 16 parts, Rhizoma Gastrodiae, 12 parts, Radix Glycyrrhizae, 8 parts of Radix Salviae Miltiorrhizaes, 13 parts, crystal sugar.
Above-mentioned facial paralysis the preparation method of topical agent, comprise the following steps:
(1) all crude drug are ready to according to institute's expense;
(2) first Santalum album, Radix Salviae Miltiorrhizae, RADIX PLATYCODI, four kinds of crude drug mixing and water addings of Poria are soaked, water consumption is 2~4 times of four kinds of crude drug weight summations, after soaking 20min, rear slow fire continuation decoction 25~30min is boiled in big fire, add Radix Glycyrrhizae, Flos Lonicerae, Rhizoma Gastrodiae, it is 20%~30% that rear continuation slow fire boiling to moisture in medicinal residues is boiled in big fire again;
(3) Rhizoma Imperatae, Periostracum Cicadae and crystal sugar are ground into powder after with after medicinal residues in step (2) mix, add the water of 2~4 times of gross weights to soak, after immersion 10min, big fire is boiled, continuation slow fire boiling to moisture in medicinal residues is 10%~15%;
(4) medicinal residues that step (3) obtained are ground to mud shape, obtain the topical agent of described facial paralysis.
Above-mentioned facial paralysis the using method of topical agent, wash away after the topical agent of described facial paralysis is coated on to facial 30min, before sleeping every day 1h and get up after 1h carry out at twice.
Beneficial effect: a kind of facial paralysis provided by the present invention preparation and the using method of topical agent, compared with prior art have the following advantages: drug effect is remarkable, cheap on the one hand, has no side effect, can not cause the dependency of patient to medicine, be difficult for recurrence; On the other hand and preparation and application simple and easy to do, do not rely on medical personnel's technology occasionality, be suitable for clinical practice.
The specific embodiment
Below in conjunction with specific embodiment, the present invention is further described:
Embodiment 1:
A topical agent for facial paralysis, comprises the crude drug of following parts by weight: Rhizoma Imperatae 6,8 parts, Poria, 10 parts of RADIX PLATYCODIs, 10 parts of Santalum albums, 10 parts of Flos Loniceraes, 6 parts of Periostracum Cicadaes, 12 parts, Rhizoma Gastrodiae, 10 parts, Radix Glycyrrhizae, 6 parts of Radix Salviae Miltiorrhizaes, 10 parts, crystal sugar.
Above-mentioned facial paralysis the preparation method of topical agent, comprise the following steps:
(1) all crude drug are ready to according to institute's expense;
(2) first Santalum album, Radix Salviae Miltiorrhizae, RADIX PLATYCODI, four kinds of crude drug mixing and water addings of Poria are soaked, water consumption is 2 times of four kinds of crude drug weight summations, after soaking 20min, rear slow fire continuation decoction 25min is boiled in big fire, add Radix Glycyrrhizae, Flos Lonicerae, Rhizoma Gastrodiae, it is 20% that rear continuation slow fire boiling to moisture in medicinal residues is boiled in big fire again;
(3) Rhizoma Imperatae, Periostracum Cicadae and crystal sugar are ground into powder after with after medicinal residues in step (2) mix, add the water of 2 times of gross weights to soak, after immersion 10min, big fire is boiled, continuation slow fire boiling to moisture in medicinal residues is 10%;
(4) medicinal residues that step (3) obtained are ground to mud shape, obtain the topical agent of described facial paralysis.
Above-mentioned facial paralysis the using method of topical agent: after the topical agent of described facial paralysis is coated on to facial 30min, wash away, before sleeping every day 1h and get up after 1h carry out at twice.
Embodiment 2:
A topical agent for facial paralysis, comprises the crude drug of following parts by weight: 7 parts of Rhizoma Imperataes, 10 parts, Poria, 13 parts of RADIX PLATYCODIs, 11 parts of Santalum albums, 15 parts of Flos Loniceraes, 7 parts of Periostracum Cicadaes, 16 parts, Rhizoma Gastrodiae, 12 parts, Radix Glycyrrhizae, 8 parts of Radix Salviae Miltiorrhizaes, 13 parts, crystal sugar.
Above-mentioned facial paralysis preparation and the using method of topical agent, comprise the following steps:
(1) all crude drug are ready to according to institute's expense;
(2) first Santalum album, Radix Salviae Miltiorrhizae, RADIX PLATYCODI, four kinds of crude drug mixing and water addings of Poria are soaked, water consumption is 3 times of four kinds of crude drug weight summations, after soaking 20min, rear slow fire continuation decoction 28min is boiled in big fire, add Radix Glycyrrhizae, Flos Lonicerae, Rhizoma Gastrodiae, it is 25% that rear continuation slow fire boiling to moisture in medicinal residues is boiled in big fire again;
(3) Rhizoma Imperatae, Periostracum Cicadae and crystal sugar are ground into powder after with after medicinal residues in step (2) mix, add the water of 3 times of gross weights to soak, after immersion 10min, big fire is boiled, continuation slow fire boiling to moisture in medicinal residues is 13%;
(4) medicinal residues that step (3) obtained are ground to mud shape, obtain the topical agent of described facial paralysis.
Above-mentioned facial paralysis the using method of topical agent: after being coated on facial 30min, wash away, before sleeping every day 1h and get up after 1h carry out at twice.
Embodiment 3:
A topical agent for facial paralysis, comprises the crude drug of following parts by weight: 8 parts of Rhizoma Imperataes, 12 parts, Poria, 15 parts of RADIX PLATYCODIs, 12 parts of Santalum albums, 20 parts of Flos Loniceraes, 9 parts of Periostracum Cicadaes, 20 parts, Rhizoma Gastrodiae, 13 parts, Radix Glycyrrhizae, 9 parts of Radix Salviae Miltiorrhizaes, 15 parts, crystal sugar.
Above-mentioned facial paralysis preparation and the using method of topical agent, comprise the following steps:
(1) all crude drug are ready to according to institute's expense;
(2) first Santalum album, Radix Salviae Miltiorrhizae, RADIX PLATYCODI, four kinds of crude drug mixing and water addings of Poria are soaked, water consumption is 4 times of four kinds of crude drug weight summations, after soaking 20min, rear slow fire continuation decoction 30min is boiled in big fire, add Radix Glycyrrhizae, Flos Lonicerae, Rhizoma Gastrodiae, it is 30% that rear continuation slow fire boiling to moisture in medicinal residues is boiled in big fire again;
(3) Rhizoma Imperatae, Periostracum Cicadae and crystal sugar are ground into powder after with after medicinal residues in step (2) mix, add the water of 4 times of gross weights to soak, after immersion 10min, big fire is boiled, continuation slow fire boiling to moisture in medicinal residues is 15%;
(4) medicinal residues that step (3) obtained are ground to mud shape, obtain the topical agent of described facial paralysis.
Above-mentioned facial paralysis the using method of topical agent: after being coated on facial 30min, wash away, before sleeping every day 1h and get up after 1h carry out at twice.
By clinical case, further set forth below the beneficial effect of medicine of the present invention:
(1) clinical data and Therapeutic Method
With test group facial paralysis patient 50 examples, compare with matched group 50 examples. test group:chinese drugs agentia described in embodiment 1-3 and using method in the present invention, continuous use 7 days is 1 course for the treatment of; matched group:adopting conventional medicine to treat, every day three times, 7 days was 1 course for the treatment of.
Test group and matched group patient are fully recovered in 3 months and paid a return visit, investigate and record constipation disease recurrence.
(2) curative effect determinate standard
A) effective: after finishing the course for the treatment of, clinical symptoms is clearly better before treating, facial expression muscle recovers, catacleisis, and while talking and laugh, in nose, ditch and bicker are without crooked, and short-term is without recurrence;
B) effective: after finishing the course for the treatment of, facial muscle function is most of recovers normal;
C) invalid: symptom, without obviously alleviating, even increases the weight of.
(3) clinical effectiveness
Test group and the comparison of matched group curative effect, in Table 1.
Table 1 test group and the comparison of matched group curative effect
? Effective Effectively Invalid Add up to Effective percentage (%) Relapse rate (%)
Test group 28 19 3 50 94 5
Matched group 10 13 27 50 46 45
Clinical effectiveness shows: test group facial paralysis patient 50 examples, total effective rate reaches in 94%, three month 5% relapse rate, with the total effective rate of matched group 50 examples 46% and in three months 45% relapse rate compare, be obviously better than matched group.Illustrate that Drug therapy facial paralysis of the present invention is evident in efficacy, drug effect is remarkable and be difficult for recurrence, has good promotional value.
Should be understood that, the above specific embodiment is only not used in and limits the scope of the invention for the present invention is described, after having read the present invention, those skilled in the art all fall within the application's claims limited range to the modification of the various equivalent form of values of the present invention.

Claims (4)

1. the topical agent of a facial paralysis, it is characterized in that, comprise the crude drug of following parts by weight: 6~8 parts of Rhizoma Imperataes, 8~12 parts, Poria, 10~15 parts of RADIX PLATYCODIs, 10~12 parts of Santalum albums, 10~20 parts of Flos Loniceraes, 6~9 parts of Periostracum Cicadaes, 12~20 parts, Rhizoma Gastrodiae, 10~13 parts, Radix Glycyrrhizae, 6~9 parts of Radix Salviae Miltiorrhizaes, 10~15 parts, crystal sugar.
Facial paralysis according to claim 1 topical agent, it is characterized in that, comprise the crude drug of following parts by weight: 7 parts of Rhizoma Imperataes, 10 parts, Poria, 13 parts of RADIX PLATYCODIs, 11 parts of Santalum albums, 15 parts of Flos Loniceraes, 7 parts of Periostracum Cicadaes, 16 parts, Rhizoma Gastrodiae, 12 parts, Radix Glycyrrhizae, 8 parts of Radix Salviae Miltiorrhizaes, 13 parts, crystal sugar.
Facial paralysis as claimed in claim 1 the preparation method of topical agent, it is characterized in that comprising the following steps:
(1) all crude drug are ready to according to institute's expense;
(2) first Santalum album, Radix Salviae Miltiorrhizae, RADIX PLATYCODI, four kinds of crude drug mixing and water addings of Poria are soaked, water consumption is 2~4 times of four kinds of crude drug weight summations, after soaking 20min, rear slow fire continuation decoction 25~30min is boiled in big fire, add Radix Glycyrrhizae, Flos Lonicerae, Rhizoma Gastrodiae, it is 20%~30% that rear continuation slow fire boiling to moisture in medicinal residues is boiled in big fire again;
(3) Rhizoma Imperatae, Periostracum Cicadae and crystal sugar are ground into powder after with after medicinal residues in step (2) mix, add the water of 2~4 times of gross weights to soak, after immersion 10min, big fire is boiled, continuation slow fire boiling to moisture in medicinal residues is 10%~15%;
(4) medicinal residues that step (3) obtained are ground to mud shape, obtain the topical agent of described facial paralysis.
Facial paralysis as claimed in claim 1 the using method of topical agent, it is characterized in that, wash away after the topical agent of described facial paralysis is coated on to facial 30min, before sleeping every day 1h and get up after 1h carry out at twice.
CN201310683315.6A 2013-12-16 2013-12-16 A kind of topical agent of facial paralysis and preparation and application thereof Expired - Fee Related CN103690806B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310683315.6A CN103690806B (en) 2013-12-16 2013-12-16 A kind of topical agent of facial paralysis and preparation and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310683315.6A CN103690806B (en) 2013-12-16 2013-12-16 A kind of topical agent of facial paralysis and preparation and application thereof

Publications (2)

Publication Number Publication Date
CN103690806A true CN103690806A (en) 2014-04-02
CN103690806B CN103690806B (en) 2016-04-20

Family

ID=50352576

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310683315.6A Expired - Fee Related CN103690806B (en) 2013-12-16 2013-12-16 A kind of topical agent of facial paralysis and preparation and application thereof

Country Status (1)

Country Link
CN (1) CN103690806B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115737764A (en) * 2017-11-29 2023-03-07 河南中医药大学 Traditional Chinese medicine for treating acute stage of peripheral facial paralysis and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101700364A (en) * 2009-11-12 2010-05-05 张国营 Thrombolytic and lipid-lowering pill
CN101744906A (en) * 2008-12-01 2010-06-23 河北以岭医药研究院有限公司 Applications of Chinese medicinal composition to preparation of medicament for treating facial paralysis
CN103142978A (en) * 2013-03-22 2013-06-12 邓广博 Medicine for treating peripheral facial paralysis

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101744906A (en) * 2008-12-01 2010-06-23 河北以岭医药研究院有限公司 Applications of Chinese medicinal composition to preparation of medicament for treating facial paralysis
CN101700364A (en) * 2009-11-12 2010-05-05 张国营 Thrombolytic and lipid-lowering pill
CN103142978A (en) * 2013-03-22 2013-06-12 邓广博 Medicine for treating peripheral facial paralysis

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115737764A (en) * 2017-11-29 2023-03-07 河南中医药大学 Traditional Chinese medicine for treating acute stage of peripheral facial paralysis and preparation method thereof

Also Published As

Publication number Publication date
CN103690806B (en) 2016-04-20

Similar Documents

Publication Publication Date Title
Jafarpour et al. Effect of a traditional syrup from Citrus medica L. fruit juice on migraine headache: A randomized double blind placebo controlled clinical trial
CN102861274B (en) External use traditional Chinese medicine for treating eczema
CN102145061B (en) Qidan nasal allergy medicament and preparation method thereof
CN102973683A (en) Drug for treating proliferation of mammary gland, and preparation method thereof
CN102198175B (en) Chinese medicine composition
CN103690806B (en) A kind of topical agent of facial paralysis and preparation and application thereof
CN103041050B (en) Medicine for treating impetigo
CN103127401A (en) Pharmaceutical composition for treating neurasthenia and preparation method thereof
CN102429997B (en) Traditional Chinese medicine preparation for treating allergic purpura
Chen et al. Botany, traditional uses, and pharmacology of Polygonati rhizoma
CN103655903B (en) A kind of Chinese drugs agentia for the treatment of yellow hair
CN103656239B (en) A kind of Chinese drugs agentia for the treatment of wind syndrome of head and preparation method thereof
CN104784667A (en) Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases and preparation method thereof
CN104587299A (en) Traditional Chinese medicine preparation for treating gastric and duodenal ulcers
CN104107264A (en) Traditional Chinese medicine agent for treating infantile constipation and preparation method and application of traditional Chinese medicine agent
CN103127255B (en) Antioxidant externally-applied Chinese medicine dressing formula for treating asthma and preparation method thereof
CN103028055A (en) Traditional Chinese medicine for treating migraine
CN103655814B (en) One treats psoriatic Chinese medicine composition and application thereof
CN101152291A (en) Medicament for preventing and treating cardiovascular and cerebrovascular diseases, and method for preparing the same
CN111686176A (en) Tea drink for preventing normal physique population
CN101732577B (en) Medicament for treating Meniere's disease
CN103948718A (en) Traditional Chinese medicament for treating pruritus vulvae of patient with gestational diabetes and preparation method thereof
CN103690700B (en) A kind of Chinese drugs agentia for the treatment of constipation and preparation method thereof
CN103655922B (en) Chinese drugs agentia of a kind of Cure for insomnia and preparation method thereof
CN104740579B (en) Premenstrual peace piece and its preparation technology

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20160323

Address after: 325200 Wenzhou City, Ruian City, fairy street, the village of the first Village No. 115

Applicant after: Bian Jialin

Address before: 266005 Shandong Province, Qingdao city Shenxian Road No. 39 room 219

Applicant before: QINGDAO BAIRUIJI BIOTECHNOLOGY Co.,Ltd.

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160420

Termination date: 20211216

CF01 Termination of patent right due to non-payment of annual fee